Springer - Resistance to Immunotherapeutic Antibodies in Cancer

Traditional cancer treatments such as chemotherapy, radiation, and hormonal therapy often lack selectivity and can result in high toxicity. This volume explores the alternative approach of antibody-mediated anti-cancer therapy, which offers a more selective and less toxic method for treating various cancers. This book examines how monoclonal antibodies (mAbs) function to destroy malignant tumor cells and prevent growth by blocking specific cell receptors. It also addresses the potential for these therapies to reverse existing drug and radiation resistance. As part of the Resistance to Targeted Anti-Cancer Therapeutics series, this second volume provides essential knowledge for understanding how to overcome resistance in immunotherapeutic antibody treatments.